TARA
Price
$6.88
Change
+$0.08 (+1.18%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
262.01M
97 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$18.70
Change
-$0.19 (-1.01%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
957.2M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TARA vs TBPH

Header iconTARA vs TBPH Comparison
Open Charts TARA vs TBPHBanner chart's image
Protara Therapeutics
Price$6.88
Change+$0.08 (+1.18%)
Volume$5.18K
Capitalization262.01M
Theravance Biopharma
Price$18.70
Change-$0.19 (-1.01%)
Volume$6.02K
Capitalization957.2M
TARA vs TBPH Comparison Chart in %
TARA
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TARA vs. TBPH commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TARA is a Hold and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (TARA: $6.80 vs. TBPH: $18.89)
Brand notoriety: TARA and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TARA: 278% vs. TBPH: 120%
Market capitalization -- TARA: $262.01M vs. TBPH: $957.2M
TARA [@Biotechnology] is valued at $262.01M. TBPH’s [@Biotechnology] market capitalization is $957.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TARA’s FA Score shows that 1 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • TARA’s FA Score: 1 green, 4 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TARA is a better buy in the long-term than TBPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TARA’s TA Score shows that 3 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).

  • TARA’s TA Score: 3 bullish, 6 bearish.
  • TBPH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than TARA.

Price Growth

TARA (@Biotechnology) experienced а -8.17% price change this week, while TBPH (@Biotechnology) price change was -5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

TARA is expected to report earnings on Mar 11, 2026.

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($957M) has a higher market cap than TARA($262M). TBPH YTD gains are higher at: 100.744 vs. TARA (28.788). TBPH has higher annual earnings (EBITDA): 46.1M vs. TARA (-57.01M). TBPH has more cash in the bank: 339M vs. TARA (122M). TARA has less debt than TBPH: TARA (3.95M) vs TBPH (46.5M). TBPH has higher revenues than TARA: TBPH (77.2M) vs TARA (0).
TARATBPHTARA / TBPH
Capitalization262M957M27%
EBITDA-57.01M46.1M-124%
Gain YTD28.788100.74429%
P/E RatioN/A33.14-
Revenue077.2M-
Total Cash122M339M36%
Total Debt3.95M46.5M8%
FUNDAMENTALS RATINGS
TARA vs TBPH: Fundamental Ratings
TARA
TBPH
OUTLOOK RATING
1..100
7331
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9780
PRICE GROWTH RATING
1..100
3536
P/E GROWTH RATING
1..100
10086
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (19) in the null industry is somewhat better than the same rating for TBPH (77) in the Pharmaceuticals Other industry. This means that TARA’s stock grew somewhat faster than TBPH’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as TBPH (100) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to TBPH’s over the last 12 months.

TBPH's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as TARA (97) in the null industry. This means that TBPH’s stock grew similarly to TARA’s over the last 12 months.

TARA's Price Growth Rating (35) in the null industry is in the same range as TBPH (36) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to TBPH’s over the last 12 months.

TBPH's P/E Growth Rating (86) in the Pharmaceuticals Other industry is in the same range as TARA (100) in the null industry. This means that TBPH’s stock grew similarly to TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TARATBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 28 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
TARA
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGEAF23.360.78
+3.45%
Diageo plc
BLSFF15.00N/A
N/A
Bluescope Steel, Ltd.
DMZPY7.03N/A
N/A
Domino's Pizza Australia New Zealand
GNSMF0.06N/A
N/A
MOROCCO STRATEGIC MINERALS CORP.
RRACF11.89N/A
N/A
Rigel Resource Acquisition Corp.

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with ITRM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+9.32%
ITRM - TARA
35%
Loosely correlated
+0.77%
CAMP - TARA
34%
Loosely correlated
-1.81%
BRNS - TARA
34%
Loosely correlated
+3.37%
SRRK - TARA
34%
Loosely correlated
+5.92%
TBPH - TARA
32%
Poorly correlated
+2.50%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+2.50%
KYMR - TBPH
46%
Loosely correlated
+2.68%
VYGR - TBPH
38%
Loosely correlated
+12.20%
LYRA - TBPH
36%
Loosely correlated
+4.49%
VERA - TBPH
36%
Loosely correlated
+10.77%
RGNX - TBPH
35%
Loosely correlated
+5.49%
More